Results 301 to 310 of about 11,284,409 (311)

Accurate assay of dopa decarboxylase by preventing nonenzymatic decarboxylation of dopa

Analytical Biochemistry, 1983
Sachiko Okuno, Hitoshi Fujisawa
exaly  

Some interactions of L-DOPA and its related compounds with glutamate receptors

Life Sciences, 1999
Yoshio Goshima, Takeaki Miyamae
exaly  

Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease

Journal of Pineal Research, 2006
Rossana Migheli, Bianca Marchetti, Pier Andrea Serra   +2 more
exaly  

Interaction between l-DOPA and 3-O-methyl-l-DOPA for transport in immortalised rat capillary cerebral endothelial cells

Neuropharmacology, 1999
Pedro Gomes, Patricio Soares-Da-Silva
exaly  

The prescribing of l-dopa.

The Medical journal of Australia, 1971
openaire   +2 more sources

Striatal L-DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis

Journal of Neurochemistry, 1993
Gabriel C Leger, Paul Cumming, Albert Gjedde   +2 more
exaly  

[L-Dopa].

Soins; la revue de reference infirmiere, 1985
P, Benoit, A, Peutillot
openaire   +1 more source

Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias

Experimental Neurology, 2010
Frank Schneider, Rylander Ottosson, Rudolf-Giesbert Alken   +2 more
exaly  

L-DOPA IN SENILE DEMENTIA

The Lancet, 1970
M H, Van Woert, G, Heninger, U, Rathey, M B, Bowers   +3 more
openaire   +2 more sources

Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa

Journal of Neurochemistry, 2006
Kenneth Rodgers, Roger T Dean, John G L Morris   +2 more
exaly